Long-Term Use of Different Doses of Low-Molecular-Weight Heparin Versus Vitamin K Antagonists in the Treatment of Venous Thromboembolism

Vitamin K Antagonists ◽

Low Molecular Weight ◽

Different Doses

Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd002001.pub3 ◽

2017 ◽

Author(s):

Alina Andras ◽

Adriano Sala Tenna ◽

Marlene Stewart

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

10.1002/14651858.cd002001 ◽

2001 ◽

Cited By ~ 25

Author(s):

Jeroen Frank van der Heijden ◽

Barbara A Hutten ◽

Harry R Büller ◽

Martin H Prins

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

10.1002/14651858.cd002001.pub2 ◽

2012 ◽

Cited By ~ 8

Author(s):

Alina Andras ◽

Adriano Sala Tenna ◽

Fay Crawford

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

How does low-molecular-weight heparin compare with vitamin K antagonists for long-term treatment of individuals with symptomatic venous thromboembolism?

Cochrane Clinical Answers ◽

10.1002/cca.1823 ◽

2017 ◽

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparin for prevention of venous thromboembolism following total hip or knee replacement or hip repair

10.1002/14651858.cd005981 ◽

2006 ◽

Author(s):

Carlos A Salazar ◽

German Malaga ◽

Giuliana Malasquez

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Knee Replacement ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Thrombin Inhibitors ◽

Direct Thrombin Inhibitors ◽

Low Molecular Weight ◽

Total Hip

Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

The American Journal of Medicine ◽

10.1016/j.amjmed.2017.11.042 ◽

2018 ◽

Vol 131 (4) ◽

pp. 430-437 ◽

Cited By ~ 10

Author(s):

Chatree Chai-Adisaksopha ◽

Alfonso Iorio ◽

Mark A. Crowther ◽

Javier de Miguel ◽

Estuardo Salgado ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Cancer Patients ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Low Molecular Weight

How do low-molecular-weight heparin (LMWH), vitamin K agonists (VKAs), and direct oral anticoagulants (DOACs) compare for treatment of venous thromboembolism (VTE) in people with cancer?

Cochrane Clinical Answers ◽

10.1002/cca.2813 ◽

2019 ◽

Author(s):

Simone Mocellin

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Low Molecular Weight

How do low-molecular-weight heparin (LMWH), vitamin K agonists (VKAs), and direct oral anticoagulants (DOACs) compare for treatment of venous thromboembolism (VTE) in people with cancer?

Cochrane Clinical Answers ◽

10.1002/cca.2255 ◽

2019 ◽

Author(s):

Simone Mocellin

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Low Molecular Weight

Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a reply to a rebuttal

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2005.01145.x ◽

2005 ◽

Vol 3 (3) ◽

pp. 609-610

Author(s):

S. LAPORTE ◽

M. CUCHERAT ◽

P. MISMETTI

Keyword(s):

Molecular Weight ◽

Vitamin K ◽

Orthopedic Surgery ◽

Vitamin K Antagonists ◽

Low Molecular Weight ◽

Risk Of Bleeding

Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2005.01180.x ◽

2005 ◽

Vol 3 (3) ◽

pp. 473-481 ◽

Cited By ~ 17

Author(s):

A. KHER ◽

M. M. SAMAMA

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Vitamin K Antagonists ◽

Secondary Prophylaxis ◽

Low Molecular Weight ◽

Low Molecular Weight Heparins